Marker Therapeutics Inc.
MRKR | NASDAQ
$1.20
+$0.02 (+1.69%)
At close: Sep 21, 2026, 4:00 PM ET
$1.16
-$0.04 (-3.38%)
Pre-market:
Sep 22, 2026, 7:25 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -8.71M | -10.9M | -12.16M | -14.3M | -14.61M | -12.78M | -10.73M | -9.63M | -10.31M | -12.21M | -14.05M | -15.16M | -17.91M | -23.05M | -28.74M | -34.64M | -41.35M | -43.01M | -41.88M | -40.62M | -35.56M | -31M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 971.73K | 1.94M | 1.94M | 2.78M | 2.64M | 2.49M | 3.3M | 3.24M | 3.16M | 2.81M | 2.39M | 1.75M |
Stock-Based Compensation | 518.57K | 158.4K | 537.54K | 476.95K | 496.98K | 545.59K | 245.86K | 338.69K | 460.43K | 397.83K | 978.32K | 1.55M | 1.38M | 1.38M | 2.35M | 3.1M | 4.57M | 6.22M | 5.96M | 5.75M | 5.55M | 5.26M |
Other Working Capital | -414.97K | 1.74M | -910.73K | 817.4K | 1.82M | 133.08K | 885.25K | 229.33K | 33.9K | 2.95M | 3.89M | -356.95K | -8.55M | -3.9M | -4.76M | -131.57K | 7.42M | -588.84K | 330.68K | -585.48K | -285.99K | -420.1K |
Other Non-Cash Items | -489.17K | 178.42K | n/a | n/a | n/a | n/a | n/a | -62.94K | -323.22K | -6.45M | -10.21M | -10.15M | -7.16M | 469.31K | 4.23M | 4.23M | 1.5M | n/a | n/a | n/a | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.08M | 2.64M | -388K | -996.03K | 3.23M | -333.86K | -424.87K | 783.29K | -729.35K | 3.88M | 5.87M | 1.44M | -5.15M | -2.2M | -7.45M | -702.23K | 7.59M | 3.04M | 5.47M | 3.42M | 1.26M | 185.91K |
Operating Cash Flow | -9.76M | -7.92M | -12.01M | -14.82M | -10.88M | -12.57M | -10.91M | -8.57M | -10.9M | -14.39M | -16.44M | -20.38M | -26.9M | -20.63M | -26.97M | -25.52M | -24.39M | -30.51M | -27.28M | -28.64M | -26.36M | -23.81M |
Capital Expenditures | -8 | -6 | -9 | n/a | 5 | 3 | 4 | 3 | 1 | 112.61K | 112.61K | -14.74K | 4.7M | 2.32M | -127.35K | -349.86K | -7.07M | -5.14M | -3.13M | -6.17M | -7.28M | -10.77M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.66M | 18.55M | 18.55M | 13.73M | -4.93M | -4.82M | -4.82M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.78M | 18.66M | 18.54M | 18.44M | -2.61M | -4.95M | -5.17M | -7.07M | -5.14M | -3.13M | -6.17M | -7.28M | -10.77M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 64.33K | n/a | n/a | n/a | -15.14K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 3.66K | 3.66K | 11.36K | 11.36K | 7.7K | 92.31K | 84.61K | 84.61K | 84.61K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 9.86M | 9.86M | 9.86M | 24.76M | 14.9M | 14.94M | 14.99M | 100.54K | 578.11K | 534.24K | 1.11M | 1.24M | 759.27K | 822.1K | 202.13K | 63.57K | 63.57K | -36.41K | 52.56M | 56.56M | 58.74M | 58.83M |
Net Cash Flow | 107.39K | 1.95M | -2.15M | 9.94M | 4.01M | 2.37M | 4.08M | -8.47M | -10.32M | 4.92M | 3.33M | -602.48K | -7.7M | -22.42M | -31.72M | -30.63M | -31.4M | -35.69M | 22.14M | 21.75M | 25.1M | 24.25M |
Free Cash Flow | -9.76M | -7.92M | -12.01M | -14.82M | -10.88M | -12.57M | -10.91M | -8.57M | -10.9M | -14.28M | -16.33M | -20.39M | -22.19M | -18.31M | -27.1M | -25.87M | -31.46M | -35.65M | -30.41M | -34.81M | -33.64M | -34.57M |
Adj. Free Cash Flow | -10.28M | -8.08M | -12.55M | -15.29M | -11.38M | -13.12M | -11.16M | -8.91M | -11.36M | -14.67M | -17.31M | -21.94M | -23.57M | -19.69M | -29.45M | -28.97M | -36.03M | -41.87M | -36.37M | -40.56M | -39.2M | -39.84M |
Maintenance CapEx | -8 | -6 | -9 | 5 | 11 | 9 | 12 | 10 | 7 | 112.62K | 112.62K | -14.73K | 9.42M | 9.31M | 9.31M | 9.44M | -2M | -2.34M | -2.78M | -6.17M | -7.28M | -6.94M |
Growth CapEx | n/a | n/a | n/a | -5 | -6 | -6 | -8 | -7 | -6 | -6 | -9 | -5 | -4.72M | -6.98M | -9.44M | -9.79M | -5.07M | -2.8M | -349.85K | n/a | n/a | -3.83M |
Owner Earnings | -9.76M | -7.92M | -12.01M | -14.82M | -10.88M | -12.57M | -10.91M | -8.57M | -10.9M | -14.28M | -16.33M | -20.39M | -17.47M | -11.32M | -17.66M | -16.09M | -26.4M | -32.85M | -30.06M | -34.81M | -33.64M | -30.75M |
Add to Watchlist
Select watchlists to add or remove MRKR